MedTrace Logo

The Influence of Polymeric Versus Oligomeric Enteral Feeding on Tolerance and Nutritional Status in Paediatric Intensive Care Pilot

NCT05271565 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-02-13

No results posted yet for this study

Summary

Malnutrition is associated with negative impact on morbidity and mortality of critically ill patients. Therefore, in patients unable of peroral intake, the nutritional support is indicated. The preferred form of nutritional support is enteral, the more natural form, compared to parenteral. The enteral nutrition is cheaper and is associated with better outcomes and lower incidence of associated complications. The intolerance of enteral feeding is common in critically ill patients, and is associated with insufficient energy and protein intake, that could be linked with the complications such aspiration pneumonia. The optimization of enteral feeding tolerance is therefore one of the research priorities. Implementation of feeding protocols is associated with better tolerance. The enteral feeding could be administered as a oligomeric or polymeric formula. The are preliminary data from adult population pointing at better tolerance of oligomeric feeding formula.

Conditions

  • Enteral Feeding Intolerance

Interventions

DIETARY_SUPPLEMENT

Oligomeric enteral feeding

Oligomeric enteral formula

DIETARY_SUPPLEMENT

Polymeric enteral feeding

Polymeric enteral feeding will be administered to the PICU patients

Sponsors & Collaborators

  • Masaryk University

    collaborator OTHER

  • Brno University Hospital

    lead OTHER

Principal Investigators

  • Petr Stourac, prof. MD., Ph.D., MBA · Department of paediatric anaesthesiology and intensive care medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-21
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05271565 on ClinicalTrials.gov